Paul R.

Paul R. currently serves as Vice President Program Lead at Ultragenyx, where the focus is on leading a Gene Therapy Program targeting GSDIa since January 2020. Prior roles include significant leadership positions at Constellation Pharmaceuticals, Momenta Pharmaceuticals, and ARIAD Pharmaceuticals, where responsibilities encompassed program management and strategic development across oncology and autoimmune therapeutic areas. Paul R. has a strong background in project management from earlier positions at Verastem, Agios, and Genzyme, reinforcing capabilities in clinical development and lifecycle strategy. Education includes an MBA in Marketing and Operations from UNC Kenan-Flagler and a BSc in Chemical Engineering from the University of the Witwatersrand, complemented by a certificate in Collaborative Leadership from UMass Boston.